Long-term safety and efficacy of bimekizumab in axial spondyloarthritis: 2-year results from two phase 3 studies
比美珠单抗治疗中轴型脊柱关节炎的长期安全性和有效性:两项3期研究的2年结果
期刊:Rheumatology
影响因子:4.4
doi:10.1093/rheumatology/keaf009
Baraliakos, Xenofon; Deodhar, Atul; van der Heijde, Désirée; Van den Bosch, Filip; Magrey, Marina; Maksymowych, Walter P; Tomita, Tetsuya; Xu, Huji; Massow, Ute; Vaux, Tom; Prajapati, Chetan; Manente, Myriam; Marten, Alexander; Gensler, Lianne S